A 32-year-old woman with unexplained infertility is being considered for gonadotropin therapy vs. GnRH agonist co-treatment. Which clinical feature best distinguishes the risk profile and outcome of gonadotropin monotherapy from GnRH agonist + gonadotropin combination in terms of ovarian hyperstimulation and follicle development?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.